Live Breaking News & Updates on Pharnext Sa Stock Exchange

Stay updated with breaking news from Pharnext sa stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PARIS, France, June 14th, 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | June 14, 2023 ....

United States , France General , Fabreguettes Leib , Bella Center , Euronext Growth Stock Exchange , Peripheral Nerve Society , Presse Financi , Pharnext Sa Stock Exchange , Press Release , Ith Alpha Fr001400gun7 ,

New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial, are consistent with a good safety profile and long-term treatment effect of PXT3003 measured on. | May 25, 2023 ....

United States , France General , Fabreguettes Leib , Shahram Attarian , University Hospital La Timone , Rare Diseases Network , Neuromuscular Diseases Reference Centers , Open Label Phase , Overall Neuropathy Limitation Scale , Charcot Marie Tooth Disease Type , Overall Neuropathy Limitations Scale , Neuromuscular Diseases , Diseases Network , Lead Investigator , First Double Blind Phase , Open Label Extension , Total Trial , High Dose , Low Dose , Label Extension , Meter Walk Test , Quantified Muscular Testing , Patient Global Impression , Charcot Marie Tooth Neuropathy Score , Euronext Growth , Presse Financi ,

PARIS, France, May 23th, 2023, 08:30 am CET – Pharnext SCA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | May 23, 2023 ....

United States , France General , Fabreguettes Leib , European Union , United Statesa , Eastern Europe , Latin America , Global Tech Opportunities , Euronext Growth , Presse Financi , Pivotal Phase , Pharnext Sa Stock Exchange , Press Release , Ith Alpha Fr001400gun7 ,

PARIS, France, May 22th, 2023, 08:30 am CET – Pharnext SCA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | May 22, 2023 ....

United States , France General , Hugo Brugi , Fabreguettes Leib , Edison Group , Edison Investment Research , January Neovacs , Euronext Growth , Presse Financi , Pharnext Sa Stock Exchange , Press Release , Ith Alpha Fr001400gun7 ,

PARIS, France, May 12th, 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | May 12, 2023 ....

United States , France General , Javier Granda , Fabreguettes Leib , Neurology Service , Spanish Society Of Neurology , Neuromuscular Diseases Group , Euronext Growth Stock Exchange , Spring Meeting , Neuromuscular Diseases Study Group , Spanish Society , Hospital Universitario Central De Asturias , Hospital Universitario De Cabue , Presse Financi , Pharnext Sa Stock Exchange , Press Release , Ith Alpha Fr001400gun7 ,